You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 2, 2025

Drug Price Trends for MUPIROCIN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for MUPIROCIN

Average Pharmacy Cost for MUPIROCIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
MUPIROCIN 2% CREAM 16714-0055-02 0.73614 GM 2024-12-18
MUPIROCIN 2% CREAM 21922-0029-05 0.73614 GM 2024-12-18
MUPIROCIN 2% CREAM 51672-1370-01 1.08372 GM 2024-12-18
MUPIROCIN 2% CREAM 21922-0029-04 1.08372 GM 2024-12-18
MUPIROCIN 2% OINTMENT 68462-0180-22 0.15681 GM 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for MUPIROCIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
MUPIROCIN 2% OINT,TOP AvKare, LLC 00093-1010-42 22GM 7.76 0.35273 GM 2023-06-15 - 2028-06-14 FSS
MUPIROCIN 2% OINT,TOP AvKare, LLC 51672-1312-00 22GM 7.93 0.36045 GM 2023-06-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

MUPIROCIN Market Analysis and Financial Projection

Market Analysis and Price Projections for Mupirocin Ointment

Market Overview

The global Mupirocin Ointment market is experiencing steady growth, driven by several key factors. As of 2023, the market was valued at approximately USD 463 million and is projected to reach USD 579 million by 2030, with a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period from 2024 to 2030[1].

Market Drivers

Several factors are driving the growth of the Mupirocin Ointment market:

  • Increasing Incidence of Skin and Soft Tissue Infections: The rising prevalence of skin and soft tissue infections, including impetigo, is a significant driver for the market. This trend is particularly pronounced in the Asia-Pacific region, where the burden of these infections is increasing rapidly[3].
  • Growing Demand for Effective Topical Antibiotic Treatments: The need for effective topical antibiotic treatments, especially in the face of rising antibiotic-resistant bacterial strains, is boosting the demand for Mupirocin Ointment[3].
  • Expanding Clinical Applications: The use of Mupirocin Ointment in managing various dermatological conditions, such as nasal carriage of Staphylococcus aureus and the prevention of surgical site infections, is also contributing to market growth[3].

Market Segmentation

The Mupirocin Ointment market is segmented based on several criteria:

  • Type: The market is segmented into different product types, including Below 10g, 10g-20g, and Above 20g[1].
  • Sales Channel: The market is also segmented by sales channels, including hospitals, clinics, and retail pharmacies[4].
  • Geographical Regions: North America is the largest consumption region, holding 35% of the revenue market share, followed by China with 22%[1].

Key Players

The market is highly competitive, with both multinational pharmaceutical companies and regional players. Some of the main players include:

  • Glenmark Pharms
  • Glaxosmithkline
  • SmithKline & French
  • Humanwell Healthcare
  • Taro Pharmaceutical
  • Teva
  • Perrigo
  • Hanzhou Zhuyangxin Pharmaceutical
  • GSK
  • Sun Pharmaceutical
  • Bausch Health[1].

Price Analysis

The prices of Mupirocin Ointment vary based on the quantity and type of product:

  • Topical Cream: A 15-gram supply of 2% mupirocin topical cream can cost around $68, depending on the pharmacy[2].
  • Topical Ointment: A 15-gram supply of 2% mupirocin topical ointment can range from $15.76 to $18.17[2].

In some regions, such as Australia, the prices are regulated under the Pharmaceutical Benefits Scheme (PBS). For example, the dispensed price for a 15-gram pack of mupirocin 2% cream under the PBS is around $25.95[5].

Regional Market Analysis

  • Asia-Pacific: This region is expected to witness the fastest growth during the forecast period, driven by the rising incidence of skin and soft tissue infections and the expansion of healthcare infrastructure in countries like China and India[3].
  • North America: Currently the largest consumption region, North America continues to be a significant market for Mupirocin Ointment due to its well-established healthcare system and high demand for effective topical antibiotic treatments[1].

Challenges and Opportunities

While the market is poised for growth, it also faces several challenges:

  • Antibiotic Resistance: The growing concern over antibiotic resistance may impact the market, necessitating the development of Mupirocin Ointment formulations with improved resistance profiles[3].
  • Regulatory Hurdles: Potential regulatory hurdles for new product approvals could also affect market growth[3].

However, ongoing research and development activities to explore new formulations and delivery systems for Mupirocin Ointment are expected to create new market opportunities. The anticipated patent expirations of branded Mupirocin Ointment products in the coming years are also expected to drive the entry of generic versions, further enhancing patient access and market competition[3].

Future Outlook

The Mupirocin Ointment market is expected to continue its steady growth, driven by the increasing demand for effective topical antibiotic treatments and the expanding applications of Mupirocin Ointment in various clinical settings.

"The global Mupirocin Ointment market is projected to grow at a CAGR of around 4% during the forecast period from 2023 to 2028, driven by the rising incidence of skin and soft tissue infections and the increasing prevalence of antibiotic-resistant bacterial strains"[3].

Key Takeaways

  • The global Mupirocin Ointment market is valued at USD 463 million in 2023 and is projected to reach USD 579 million by 2030.
  • The market is growing at a CAGR of 3.2% from 2024 to 2030.
  • Key drivers include the rising incidence of skin and soft tissue infections and the growing demand for effective topical antibiotic treatments.
  • North America is the largest consumption region, followed by China.
  • The market is highly competitive with major players like Glenmark Pharms and Glaxosmithkline.
  • Prices vary based on quantity and type, with a 15-gram supply of 2% mupirocin topical cream costing around $68.

FAQs

Q: What is the current market size of the Mupirocin Ointment market? A: The global Mupirocin Ointment market was valued at USD 463 million in 2023[1].

Q: What is the projected growth rate of the Mupirocin Ointment market? A: The market is projected to grow at a CAGR of 3.2% from 2024 to 2030[1].

Q: Which region is expected to witness the fastest growth in the Mupirocin Ointment market? A: The Asia-Pacific region is expected to witness the fastest growth during the forecast period[3].

Q: What are the main applications of Mupirocin Ointment? A: Mupirocin Ointment is commonly used for impetigo, nasal carriage of Staphylococcus aureus, paronychia, and other skin and soft tissue infections[2].

Q: Who are the major players in the Mupirocin Ointment market? A: Major players include Glenmark Pharms, Glaxosmithkline, SmithKline & French, Humanwell Healthcare, and others[1].

Sources

  1. Global Mupirocin Ointment Market Research Report 2024 - Valuates Reports
  2. Mupirocin topical Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com
  3. Mupirocin Ointment Market Size, Share & Forecast 2033 - Data Horizzon Research
  4. Global Mupirocin Ointment Market Size, Scope And Forecast Report - Market Research Intellect
  5. MUPIROCIN - Pharmaceutical Benefits Scheme (PBS) - PBS.gov.au

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.